Causes of acute hospitalization in adolescence: Burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: A prospective survey

PLoS Medicine

Volumn 7, Issue 2, 2010, Pages

  Ferrand, Rashida A ^a,b   Bandason, Tsitsi ^b   Musvaire, Praise ^b   Larke, Natasha ^a   Nathoo, Kusum ^c   Mujuru, Hilda ^c   Ndhlovu, Chiratidzo E ^c   Munyati, Shungu ^b   Cowan, Frances M ^d   Gibb, Diana M ^e   Corbett, Elizabeth L ^a,b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b BIOMEDICAL RESEARCH AND TRAINING INSTITUTE   (Zimbabwe)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHRONIC DISEASE; DELAYED PUBERTY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIDEMIC; FATALITY; FEMALE; HEALTH SURVEY; HEART DISEASE; HERPES SIMPLEX VIRUS 2; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PROSPECTIVE STUDY; PUBLIC HOSPITAL; QUESTIONNAIRE; SCHOOL CHILD; SEX DIFFERENCE; TUBERCULOSIS; ZIMBABWE; AIDS RELATED COMPLEX; CLINICAL TRIAL; DISEASE TRANSMISSION; MORTALITY; MULTICENTER STUDY; ONSET AGE; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; STATISTICAL MODEL; STATISTICS; SURVIVOR; VERTICAL TRANSMISSION;

ADOLESCENT; AGE OF ONSET; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CHILD; DISEASE OUTBREAKS; FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEROLOGY; SURVIVORS; ZIMBABWE;

EID: 77449111194     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000178     Document Type: Article

References (38)

1. Sells CW, Blum RW (1996) Morbidity and mortality among US adolescents: an overview of data and trends. Am J Public Health 86: 513-519.
2. Caflisch M, Alvin P (2000) Management of adolescents in pediatric hospitals. A national survey. Arch Pediatr 7: 732-737.
3. Rosen EU (1988) Adolescent health problems-can paediatricians in the RSA cope? S Afr Med J 73: 337-339.
4. Obasi AI, Balira R, Todd J, Ross DA, Changalucha J, et al. (2001) Prevalence of HIV and Chlamydia trachomatis infection in 15-19-year olds in rural Tanzania. Trop Med Int Health 6: 517-525.
5. Agyei WK, Epema EJ, Lubega M (1992) Contraception and prevalence of sexually transmitted diseases among adolescents and young adults in Uganda. Int J Epidemiol 21: 981-988.
6. Stover J, Walker N, Grassly NC, Marston M (2006) Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection package. Sex Transm Infect 82: iii45-iii50.
7. Marston M, Zaba B, Salomon JA, Brahmbhatt H, Bagenda D (2005) Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics. J Acquir Immune Defic Syndr 38: 219-227.
8. Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Nunn A, et al. (2006) Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr 42: 637-645.
9. Ferrand RA, Luethy R, Bwakura F, Mujuru H, Miller RF, et al. (2007) HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe. Clin Infect Dis 44: 874-878.
10. UNAIDS (2008) Report on the global HIV/AIDS epidemic. Geneva: UNAIDS.
11. Ferrand RA, Corbett EL, Wood R, Hargrove J, Ndhlovu CE, et al. (2009) AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. Aids 23: 2039-2046.
12. Shah I (2005) Age related clinical manifestations of HIV infection in Indian children. J Trop Pediatr 51: 300-303.
13. Bakaki P, Kayita J, Moura Machado JE, Coulter JB, Tindyebwa D, et al. (2001) Epidemiologic and clinical features of HIV-infected and HIV-uninfected Ugandan children younger than 18 months. J Acquir Immune Defic Syndr 28: 35-42.
14. Bobat R, Coovadia H, Moodley D, Coutsoudis A (1999) Mortality in a cohort of children born to HIV-1 infected women from Durban, South Africa. S Afr Med J 89: 646-648.
15. Grant AD, Djomand G, Smets P, Kadio A, Coulibaly M, et al. (1997) Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Cote d'Ivoire. AIDS 11: 1357-1364.
16. World Health Organization (2005) Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance- African Region. Geneva: World Health Organization.
17. Archibald LK, McDonald LC, Addison RM, McKnight C, Byrne T, et al. (2000) Comparison of BACTEC MYCO/F LYTIC and WAMPOLE ISOLATOR 10 (lysis- centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country. J Clin Microbiol 38: 2994-2997.
18. Cole TJ (1997) Growth monitoring with the British 1990 growth reference. Arch Dis Child 76: 47-49.
19. Victora CG, Huttly SR, Fuchs SC, Olinto MT (1997) The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol 26: 224-227.
20. Corbett EL, Churchyard GJ, Charalambos S, Samb B, Moloi V, et al. (2002) Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis 34: 1251-1258.
21. Grant AD, Sidibe K, Domoua K, Bonard D, Sylla-Koko F, et al. (1998) Spectrum of disease among HIV-infected adults hospitalised in a respiratory medicine unit in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis 2: 926-934.
22. Jeena PM, Coovadia HM, Thula SA, Blythe D, Buckels NJ, et al. (1998) Persistent and chronic lung disease in HIV-1 infected and uninfected African children. Aids 12: 1185-1193.
23. Arpadi SM (2000) Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 25: S37-S42.
24. Buchacz K, Rogol AD, Lindsey JC, Wilson CM, Hughes MD, et al. (2003) Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection. J Acquir Immune Defic Syndr 33: 56-65.
25. Weiss HA, Buve A, Robinson NJ, Van Dyck E, Kahindo M, et al. (2001) The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 15: S97-S108.
26. Gregson S, Nyamukapa CA, Garnett GP, Mason PR, Zhuwau T, et al. (2002) Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet 359: 1896-1903.
27. Lopman BA, Garnett GP, Mason PR, Gregson S (2005) Individual level injection history: a lack of association with HIV incidence in rural Zimbabwe. PLoS Med 2: e37. doi:10.1371/journal.pmed.0020037.
28. Gomo E, Rusakaniko S, Mashange W, Mutswanga J, Chandiwana B, et al. (2005) Household survey of HIV-prevalence and behaviour in Chimanimani District, Zimbabwe. Cape Town, South Africa: Human Social Research Council.
29. Brookes H, Shisana O, Richter L (2004) The national household HIV prevalence and risk survey of South African children. Cape Town: Human Social Research Council.
30. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, et al. (2004) Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364: 1236-1243.
31. Soh CH, Oleske JM, Brady MT, Spector SA, Borkowsky W, et al. (2003) Longterm effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet 362: 2045-2051.
32. Walker AS, Doerholt K, Sharland M, Gibb DM (2004) Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV. Paediatric Study Aids 18: 1915-1924.
33. Newell ML, Patel D, Goetghebuer T, Thorne C (2006) CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis 193: 954-962.
34. Bakeera-Kitaka S, McKellar M, Snider C, Kekitiinwa A, Piloya T, et al. (2008) Antiretroviral therapy for HIV-1 infected adolescents in Uganda: assessing the impact on growth and sexual maturation. Pediatr Infect Dis J 3: 97-104.
35. Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, et al. (2008) Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr 49: 384-392.
36. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, et al. (2006) Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 10: S85-S93.
37. Ferrand RA, Lowe S, Whande B, Munaiwa L, Langhaug L, et al. (2009) Survey of children accessing HIV services in a high HIV prevalence setting: time for HIV-infected adolescents to count? Bull World Health Organ;In press.
38. Ministry of Health and Child Welfare (2007) Zimbabwe national HIV and AIDS estimates 2007. Harare, Zimbabwe: Ministry of Health and Child Welfare.